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I. INTRODUCTION
A. Malondialdehyde (MDA)
MDA (1,3- propanedial) is a three carbon dialdehyde shown to be produced 
in significant quantities both in vitro and in vivo.l It was first detected as an end-product 
of lipid peroxidation, oxidation of unsaturated fatty acids2 (Figure 1). MDA is also pro­
duced enzymatically as a side product of prostaglandin biosynthesis. Prostaglandins are 
synthesized in vivo by the oxidative cyclization of polyunsaturated fatty acid.3,4 The cy­
clic peroxide (PGH2), derived from arachidonic acid, is the key intermediate which 
degrades to MDA by two different prostaglandin synthases, thromboxane synthase5 and 
prostacyclin synthase6. Thromboxane synthase generates one molecule of MDA for 
every prostaglandin, thromboxane A2, formed (Figure 2).
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Figure 1. Non-enzymatic formation of MDA
2o o
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Figure 2. Enzymatic formation of MDA via thromboxane synthase
Chemical modifications of nucleosides followed by replication of the muta­
tional event are believed to initiate carcinogenesis. MDA has been reported as a carcin­
ogen7, a mutagen8 and as being toxic7 9. Its mutagenicity has been well characterized 
both in bacterial10 and mammalian cells.11 Because of its genotoxicity, mutagenicity, 
and reaction with nucleic acid bases12, MDA has sparked a great deal of interest in its 
potential carcinogenicity.
Among structurally-related compounds, MDA is unique in that it produces 
frameshift mutations whereas the others such as methyl glyoxal and acrolein, induce 
base-pair substitutions.13 MDA forms several different adducts with deoxyribonucleo-
d
3sides but it is not certain which adduct causes the frameshift mutations (Figure 3).
Dimer MDA Adduct
Figure 3. Structures of MDA adducts to guanosine, adenosine and cytosine 
The adducts can be divided into two main categories; monomer and polymer. 
Monomer adducts are formed from a single molecule of MDA, while polymer adducts
4are formed from polymers of MDA. MDA polymerizes due to its unique ability to exist 
as an enolate ion at physiological pH (pKa = 4.46 at 25°C12). The enolate ion serves 
both as an electrophile (elec) and a nucleophile (nuc) which readily condense to form 
dimers, trimers, and other polymers (refer to Figure 4).
O nuc
NaOH
pKa4.46
Enolate ion
MDA P-Hydroxy acrolein
MDA
dimerP-Hydroxy acrolein
trimer
Figure 4. MDA dimer and trimer formation
Ideally, a single adduct on a replicating genome could simulate the in vivo pro­
cess by which MDA mutagenesis would occur. With recent advances in oligonucleotide 
chemistry and gene splicing, techniques have been developed which construct biologi­
cally active genomes with individual DNA adducts at defined sites. This technique is
5known as site-specific mutagenesis.
The most efficient method for constructing a singly-modified genome utilizes a 
gapped heteroduplex, an approach developed by Romano and coworkers14. The gap in 
the genome provides the sequence into which a singly adducted complementary oligonu­
cleotide is ligated (refer to Figure 5).
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Figure 5. M13 gapped heteroduplex approach to site-specific mutagenesis
This study involves the synthesis of a small oligonucleotide with a single MDA 
derived adduct at a specific site. Once constructed the nucleotide could then be inserted 
into the gapped heteroduplex15 for site-specific mutagenesis studies. From this tech­
nique, many questions dealing with the mechanism of mutagenesis could be answered: 
Of the numerous MDA adducts which adduct causes frameshift mutations? Is a specific 
site on the genome important for mutations?
The adduct of interest was rationalized as the 3-(3-D-er7f/zA-0-pentofuranosyl-
pyrimido[l, 2-a]purin-10(3H)-one (PyP in Figure 3) adduct because of the following ob­
servations: 1. (3-substituted acroleins with good leaving groups cause frameshift muta­
6tions and are thus believed to have a similar mechanism of adduct formation as MDA16;
2. Acridine dyes, planar aromatic molecules, which are very similar in structure to PyP, 
also cause frameshift mutations. 3. Of the four bases in DNA, 2’-Deoxyguanosine is 
the most reactive towards MDA; and 4. The adducts found in vitro formed from dimers 
and trimers of MDA do not seem plausible for an in vivo study since MDA is very reac­
tive.
Constructing the PyP oligonucleotide proposes many synthetic challenges. MDA 
adducts to deoxyguanosine are very unstable. They are sensitive to both acidic and 
basic conditions. MDA in solution pH > 5 is in its ionic form (pKa = 4.46 at 25°C)17. 
Once in the enolate form as (3-hydroxy acrolein, MDA can form dimers and trimers 
(Figure 4) to result in additional adduct formation. (Refer to Figure 3 for adducts of 
dimer18 and trimer 19 MDA). Yields for PyP-dR are reportably poor, 1.86%.12 As a re­
sult of the numerous problems mentioned with MDA, 7-Me-PyP appears a good candi­
date to study. a-Me-MDA (used to form the 7-Me-PyP), unlike MDA, does not form 
polymers (dimers and trimers). The structure of 7-Me-PyP is very similar to PyP and 
therefore appears a viable substitution for PyP (Figure 6).
O O
7-Me-PyP
Figure 6. MDA adduct PyP structural comparison with 7-Me-PyP
7B. T4-RNA Ligase
The construction of the oligonucleotide with the site specific adduct wasce ac­
complished enzymatically by a method developed by Brennan and Gumport20 utilizing 
T4-RNA ligase. The technique is especially useful for the synthesis of oligonucleotides 
with base labile adducts, such as PyP or 7-Me-PyP, since the reaction is carried out in a 
physiological pH. The uniqueness of the enzyme, T4-RNA ligase, is its low selectivity 
which enables it to ligate DNA and adducted DNA as well as RNA.21
T4-RNA ligase catalyzes the ligation of a donor, 5’-phosphate to an acceptor, 
3’-OH. The acceptor must be at least 3 residues in length. The donor can be as small as 
one nucleoside, preferably 5’, 3’-bisphosphorylated. The 3’-phosphate on the donor in­
hibits the ligation from continuing and prevents multiple ligations of the donor. The 
3’-OH on the acceptor molecule is required for ligation.22 Shown below is a simple 
equation for the ligation of the deoxyribonucleotide substrates employed.
dCpdGpdC + pdG*p T4-RNA Ligase dCpdGpdCpdG*p 
(acceptor) (donor)
The mechanism of T4-RNA ligation21 appears analogous to DNA ligation.23 
Two key intermediates are involved in the ligation process. Both are covalent complex­
es and have been isolated; the adenylylated enzyme24 and the transfer of the adenyl 
group of the enzyme to the 5’-phosphate donor to form an ado-5’diphosphate-5’- 
oligonucleotide.25’26 The mechanism is illustrated in Figure 7 with the substrates of 
interest.
The substrates employed are the adduct as mentioned, 7-Me-PyP-dR with 
phosphates in the 5’ and 3’ positions, and the trimer, dCpdGpdC. dCpdGpdC was
selected due to the occurrence of frameshift mutations in Salmonella typhimuriunm 
/z/sD3052, “GC”-rich regions.27 With the use of these substrates an adducted 
oligonucleotide, dCpdGpdCpdeGp, can be utilized for further studies in site-specific
mutagenesis.
9E-(Lys)-NH}
«...
E-(Lys)-NH>
0 0 0 0
E-(Lys)-+NH2 ' P.
A^O"A
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O,
°V0' II
^ n°^yyg
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(1 P-
O. JG*
Figure 7. Mechanism of T4-RNA ligation, E = T4-RNA Ligase, G* = Ethenoguanine
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II. EXPERIMENTAL
A. Materials
Benzoyl chloride and crotonaldehyde were purchased from Aldrich. All HPLC 
grade solvents were obtained from American Scientific. 2-Methyl-1, 1, 3, 3- tetraethoxy 
propane was a gift from K. Stone, Wayne State University, Detroit. 3’, 5’-Bisphos- 
phoryl-2’-deoxyguanosine (Na+) was purchased from Pharmacia LKB. Adenylate ki­
nase (myokinase grade V, pig muscle dialyzed in 50 mM HEPES-NaOH, 5,000 
units/ml), bovine serum albumin, creatine phosphokinase (type 1 rabbit muscle, 1750 
units/ml), dithiothreitol, HEPES-NaOH, hexamine cobalt (III) chloride, phospho- 
creatine, pyrophosphoryl chloride (CAUTION: extremely corrosive), spermine, and tri- 
ethylamine were all purchased from Sigma. Adenosine-5’-triphosphate (Na+) and 2’- 
deoxyguanosine were obtained from United States Biochemical Corp. T4-RNA ligase 
was purchased from three different companies with three different specific activities: 
Pharmacia (9000 units/ml), Bethesda Research Laboratories (6000 units/ml) and New 
England Biolabs (4000 units/ml). All other reagents were reagent grade and purchased 
from standard chemical companies.
B. Instrumentation
HPLC was performed on a Varian Vista 5000 LC with a Varian 2050 variable 
wavelength absorbance monitor. Fluorescence was monitored by the Kratos 
Fluorescence Detector. The columns used were a Beckman Ultrasphere ODS (5|i, CJ8, 
4.6 mm x 25 cm) for analytical purposes and an Altex Ultrasphere ODS (5|U, C]8, 10
11
mm x 25 cm) which was used for preparatory or large scale purifications All analytical 
columns were run at a flow rate of 1 ml/min unless otherwise specified.
]H-NMR (Proton Nuclear Magnetic Resonance) were recorded on a General 
Electric QE 300 Fourier transform spectrometer. dCdGdC was synthesized on a 
Beckman System 1 plus DNA Synthesizer at the Molecular Biology Center at Wayne 
State University.
C. Synthesis
1. a-Methyl Malondialdehyde (a-Me-MDA)28
In a 10 ml round bottom flask, 1.176 g (5.0 mmol) a-Me-TEP, 1 ml 1 M HC1, 
and 2.5 ml distilled H90 were combined. The solution was stirred for 1 hr at 70°C. 
After cooling, 5 M NaOH was added dropwise to pH 9. The reaction mixture was evap­
orated in vacuo and the residue dissolved in 10 ml anhydrous ethanol. The solution was 
filtered to remove NaCl and concentrated in vacuo . The crude product was dissolved in 
a minimal amount of ethanol and benzene added dropwise to precipitate the sodium salt 
of a-Me-MDA. The mixture was stored at 0°C overnight and the white precipitate was 
filtered and washed with cold ethanol to yield 0.968 g Na-a-Me-MDA (70%).
!H-NMR (300MHz, D20): 8 (ppm) 1.54 (s, 3H, -CH3), 8.45 (s, 2H, -CHO). 2
2. 2’-Deoxy-7-methyl-3-(P-D-pentofuranosyl)-pyrimido [1, 2-a] purine-10-(3H)- 
one (7-Me-PyP-dR).
The procedure was adapted from Stone29 in which Na-a-Me-MDA 0.120 g
12
(1.40 mmol) was dissolved in 1 ml distilled H^O and acidified to pH 3.5. a-Me-MDA 
was extracted three times with 4 ml of Et20. The ether extracts were combined and 
evaporated in vacuo, without heating. 2’-Deoxyguanosine (dG), 50.5 mg (0.189 
mmol), was dissolved in 4 ml DMSO in a 10 ml round bottom flask and a few mg 
MgS04 added. The reaction was stirred for 24 hr at 50°C then placed on a high vacuum 
line (0.3 torr) to remove the DMSO.
The crude product was chromatographed on a Baker C18, reverse phase MPLC 
column with 15% CH3CN/H20 at a flow rate of 4 ml/min . Fractions were collected by 
monitoring for yellow color and fluorescence. The reaction mixture was separated by 
HPLC on an analytical reverse phase C18 column (4 x 250 mm). Three UV-active (254 
nm) peaks were resolved with 20 min of H^O followed by a gradient of 0-15% 
CH2CN/H20 in 10 min. The first peak eluting at 23.5 min corresponded to starting ma­
terial. The second peak eluted at 28.7 min and possessed fluorescence and NMR prop­
erties indicative of 7-Me-PyP. The third peak eluted at 32.5 min and possessed spectral 
properties characteristic of 7-Me-PyP-dR. The isolated yield was 25%. ]H-NMR 
(300MHz, D20): 5 (ppm) 2.4 (s, 3H, -CH3), 2.6 (m, 1H, H2”,), 2.8 (m, 1H, H2’), 3.75 
(m, 2H, H5’’5”), 4.2 (dt, 1H, H4’), 4.6 (dt, 1H, H3’), 6.4 (t, 1H, H1’), 8.4 (s, 1H, H2), 8.9 
(s, 1H, H6), 9.1 (s, 1H, H8)
3. Bisphosphorylation Attempts on 2’-Deoxyguanosine
In a 5 ml pear-shaped round bottom flask, 7.3 mg dG (27.3 jimol), dried over 
P?05 in a vacuum desicator overnight, 3ml dry THF, dry molecular sieves (3A) and a
13
stir bar were cooled to -40°C (ethylene glycol/CG2 bath). Pyrophosphoryl chloride, 100 
pi (0.73 mmol, p = 1.85 g/ml) was then added (under N2). After 5 hr, the reaction was 
cooled to -78°C (acetone/CO?) and quenched with frozen 0.5 M triethylammonium bi­
carbonate (TEAB), pH 7.5 then allowed to warm to room temperature.
The sample was evaporated in vacuo, redissolved in MeOH and evaporated in 
vacuo again (to remove excess TEAB). The crude product was diluted in 0.1 M TEAB, 
pH 7.5, filtered and run on an HPLC. The gradient used was 0-30% 0.1M TEAB pH 
7.5/CH^CN in 20 min on a Beckman reverse phase C18 analytical column (4 x 250 mm). 
Three major peaks were detected by UV (254 nm) and determined based on purchased 
standards (run on the same gradient) to be: 14.2 min, 3’-dGMP; 15.0 min, 5’-dGMP and 
at 15.6 min., dG.
4. Synthesis of (3-Benzoyloxy-a-methylacrolein
In a dry 10 ml round bottom flask, 0.253 g (2.3 mmol) Na-a-Me-MDA, dried 
over P?Os in a vacuum desicator, was suspended in 6 ml anhydrous THF. Benzoyl 
chloride, 0.326 g (2.3 mmol, 0.27 ml) was slowly added with vigorous stirring at 
ambient temperature. The mixture stirred for lhr then the solid was filtered off (NaCl). 
The filtrate was evaporated in vacuo . The solid was redissolved in ether, washed 
quickly with cold sat'd NaHCO^ and once with cold H90, dried with MgS04, and im­
mediately filtered. White needles formed in the filtrate. The solid, (3-benzoyloxy-a- 
methylacrolein, was filtered and weighed at 1.2 mg. The filtrate was evaporated in 
vacuo and recrystallized in ether/hexane. The second precipitate, was filtered for a total
14
yield of 0.2316 g (53%). 'H-NMR (300MHz, CDC13): 5 (ppm) 2.0 (s, 3H,-CH3), 7.6 
(m, 2H, m-Ph-H), 7.7 (dd, 1H, p-Ph-H), 8.2 (dd, 2H, o-Ph-H), 8.3 (s, 1H, C=CH), 9.6 (s, 
1H, -CHO). The mass spectrum was also indicative of the product containing a molec­
ular ion at 190, Ph-GEO+ at 105 and the phenyl cation at 77.
5. Attempted Synthesis of 7-Me-PyP-dR from [3-Benzoyloxy-a-methylacrolein
In a 5 ml pear shaped round bottom flask, dG 31.0 mg (0.116 mmol, dried over 
Pn03 in a vacuum desicator) 0.5 ml dry DMSO, a few mg MgS04 and 27.2 mg (3- 
benzoyl-oxy-a-methylacrolein (0.143 mmol) were combined and stirred for 4 days 
under N-,. The mixture was then vortexed and filtered to remove the benzoic acid and 
MgS04. The solution was placed on the rotary evaporator attached to a high vacuum 
pump to remove the DMSO.
A short MPLC column containing Baker reverse phase C18 packing (2.5 x 30 
cm) eluted with 15% CH^CN/P^O at a flow rate of 4 ml/min the crude product. A peak 
eluted after 45 min which contained the characteristic yellow fluorescence of 7-Me-PyP- 
dR. The peak was collected and subsequently run on a reverse phase C]X Beckman ana­
lytical HPLC column (4 x 250 mm), 0-30% CH^CN/O.IM TEA A pH 6.5 in 30 min. A 
band at 20 min coeluted with a 7-Me-PyP-dR standard. Unfortunately, 'H-NMR re­
vealed mostly TEA and benzoic acid. The product was quantitatively too small to dis­
tinguish.
15
6. Attempted Synthesis of 7-Me-PyP-pdRp by (3-Benzoyloxy-a-methylacrolein
3’, 5’-Bisphosphoryl-2’-deoxyguanosine (pdGp, 8.1 mg, 16 (imol) was placed 
in a 5 ml pear shaped round bottom flask with 0.5 ml dry DMSO, under N9. (3- 
Benzoyloxy-a-methylacrolein, 24.8 mg, was then added along with a few mg of 
MgS04. The reaction stirred at room temperature. After two days, the fluorescence 
characteristic of 7-Me-PyP formation was not evident so 3 ml of 0.1 M TEAA, pH 6.5 
was added (in case benzoic acid formation was depurinating the starting material). After 
six days, the filtered reaction mixture was run on reverse phase C]S analytical HPLC 
column (4 x 250 mm), 0-30% CH^CN/0.1 M TEAA pH 6.5 in 30 min. Fluorescence, 
indicative of the 7-Me-PyP adducts, (^ex = 342 nm, A,cm = 370 nm), was not detected.
7. Attempted Synthesis of 7-Me-PyP-pdRp from a-Me-MDA
pdGp (20.5 mg, 40 (imol) was placed in a 10 ml round bottom flask with 450 
|il DMSO. (The bisphosphate did not dissolve completely). Na+-a-Me-MDA, 150 mg, 
was hydrolyzed to the free acid form. The salt was dissolved in 1 ml H90 and the pH 
lowered to 4.0. The acid, a-Me-(3-hydroxyacrolein, was then extracted with 3 x 3 ml 
ether and the ether extracts were evaporated in vacuo without warming. DMSO (150 
Hi) was added to the a-Me-(3-hydroxyacrolein. The a-Me-(3-hydroxyacrolein/DMSO 
(50 |il) was added to the pdGp along with a few mg of MgS04. The reaction mixture
d
16
was then heated to 37°C.
After three days, the crude product was run on the HPLC reverse phase CJ8 
preparatory column. The gradient used was 0-10% CH^CN/ 0.1M TEAB (pH 7.5) in 30 
min. Various peaks were collected and analyzed by 'H-NMR. Peaks at 16.6 and 17.6 
min appeared to contain Oxa and PyP yet the 1 H-NMR were not conclusive due to the 
low mass.
8. Synthesis of 3’, 5’-Bisphosphoryl-2’-deoxy-l, N - ethenoguanosine (pdeGp)
2, 3-Epoxybutanal was prepared by the method of Wellman and co-workers.30 
It was obtained in a 40% yield and its 1 H-NMR corresponded to literature values.31 *H- 
NMR (300MHz, CDC13): 5 (ppm) 1.5 (d, 3H, -CH3), 3.1 (m, 1H, H3), 3.3 (m, 1H, H2), 
9.0 (d, 1H, -CHO).
3’, 5’-Bisphosphoryl-2’-deoxyguanosine (10.3 mg, .02 mmoles) was placed in 
a 5 ml pear shaped round bottom flask. 2, 3-Epoxybutanal (10 p.1) was added. Distilled 
water (2.6 ml) was then added and the pH was raised to 10. The reaction stirred vigor­
ously for 3.5 hr at room temperature. Afterwards, the solution was neutralized with 0.1 
M HC1, evaporated in vacuo, redissolved in 0.1 M TEAB pH 7.5, filtered and run on an 
HPLC. The crude mixture was separated on a Rainin DYNAMAX reverse phase C18 
column (21.4 x 250 mm) with a gradient of 0 to 9% CH3CN/0.1M TEAB pH 7.5 in 35 
min.
The major peak eluting at 31.2 min appeared to be product, pdeGp, by 'H- 
NMR. The product was reinjected onto the DYNAMAX HPLC reverse phase C]8 col­
17
umn, collected then tested for purity onaC,8 analytical column. The overall yield of 
the reaction was 35% (0.01695 mmoles). The 5H-NMR was indicative of the ethe- 
noguanosine adducts previously cited in literature.32 ’H-NMR (300MHz, D20) 8 
(ppm): 2.7 (m, 1H, H2”), 3.0 (m, 1H, H2’), 4.2 (d, 2H, H5 ,5”), 4.5 (m, 1H, H4’), 5.1 (m, 
1H, H3’), 6.5 (m, 1H, H1’), 7.4 (d, 1H, H7), 7.6 (d, 1H, H6), 8.4 (s, 1H, H2).
9. Synthesis of dCpdGpdCpdeGp
The T4-RNA ligase reaction procedure was followed from Gumport33 35 in 
which the nucleotides (pdeGp, 4 mM, ~12xl0332), oligo (dCpdGpdC, ImM), sper­
mine (8 mM), phosphocreatine (40 mM), ATP (0.4 mM), and HCC (10 mM) were dried 
under vacuum in a 1.5 ml screw-top Eppendorf plastic tube. Upon completion of dry­
ing, the following were added to a total volume of 10 ql: 50 mM HEPES-NaOH (pH 
7.9), 10 qg/ml BSA, 20 mM DTT, 5 mM MnCl2, and H20 (nano-pure), myokinase 
(-1690 units), phospho-creatine kinase (1750 units) and T^-RNA Ligase(15-50 units). 
The reaction tubes were incubated at 17°C for 1-10 days (Heated H20 bath in the cold 
room, tubes were submerged to avoid a change in concentration by evaporation or 
condensation).
Samples were prepared for the HPLC by first stopping the ligation with EDTA 
(9 jLil EDTA for every 1 ql aliquote of reaction mixture) then precipitating the enzyme 
with CH3CN/H20 with a total percentage of 50% acetonitrile (e.g. For a 1 ql aliquote of 
ligation mixture, 9 ql EDTA, 15 ql H20 and 25 ql CH^CN were added). The Eppendorf 
tubes were spun for 5 min to pellet the enzyme. The supernatant was then removed and 
placed into a new tube and dried. The residue was redissolved in 50 ql 1100 and
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injected onto the HPLC.
The mixture was separated on a reverse phase CJ8 analytical HPLC column. 
The solvent system used was a shallow gradient from 0-12% CH^CN/50 mM TEAB pH 
7.3 in 30 min. then a sharp increase from 12-30% CH^CN/50 mM TEAB pH 7.3 in 5 
min. The column was washed with 100% CH^CN for 10 min after every injection. For 
a typical chromatigraph refer to Figure 8.
Figure 8. UV profile of reverse-phase C18 column separation. Samples were run with a gradient from 0-12% • 
CH3CN/5O mM TEAB pH 7.3 in 30 min. A = ATP, B = pdeGp, C = dCpdGpdC, D = dCpdGpdCpdGp
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III. RESULTS
A. Synthesis of 7-Me-PyP-dR
a-Me-MDA was hydrolyzed and combined with 2’-deoxyguanosine to 
produce 7-Me-PyP-dR (refer to Figure 9).
Figure 9. Synthesis of 7-Me-PyP-dR
Various conditions were utilized in order to maximize the yield of 7-Me-PyP- 
dR with as little depurination as possible. Two molecules of water are eliminated in the 
formation of PyP, therefore materials were included to enhance the removal of water 
(e.g. molecular sieves (3A) and MgS04).
Apparently, water was not the only thing trapped in the molecular sieves. 
Reactions which contained molecular sieves (3A) yielded less of the 7-Me-PyP-dR, the 
desired product, than reactions containing MgS04 (refer to Figure 10). Any reactions 
containing the molecular sieves also produced more depurinated product than 7-Me- 
PyP-dR (refer to Figure 11). MgS04 seemed to enhance the formation of product before 
it depurinated (refer to Figure 12).
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Molecular sieves (3A)
Time (hr)
Figure 10. 7-Me-PyP-dR formation influenced by MgS04 and Molecular sieves (3A). Formation is 
denoted by height of fluorescent (\x= 342, ^em= 370) Peaks eluting from C18 analytical HPLC 
column.
7-Me-PyP
7-Me-PyP-dR
Time (hr)
Figure 11. Molecular sieves enhanced production of depurinated over deoxyribose, 7-Me-PyP.
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7-Me-PyP-dR
7-Me-PyP
Time (hr)
Figure 12. MgSO^ enhanced production of 2-’deoxyribose (dR) over depurinated, 7-Me-PyP
A second approach to increasing the product yield was to vary the temperature. 
Heat seemed to increase the amount of product, but with the increase in temperature 
time became a crucial factor. At 50°C a maximum yield was obtained in one day but 
after six hours depurination became faster than product formation (refer to Figure 13).
Concentrating the reactants in DMSO improved the yield of 7-Me-PyP-dR.
The estimated solubility of dG in DMSO was 0.115 g/ml and the estimated solubility of 
a-Me-(3-hydroxy acrolein was 0.272 g/ml. The optimal concentrations were found to be 
1 mM dG and 10 mM a-Me-(3-hydroxyacrolein.
Maximum yield for 7-Me-PyP-dR was obtained under the following 
conditions; MgS04 addition, maintain temperature at 50°C for 6 hr, and highly 
concentrated reactants. The yield of 25% was much greater than a previously published 
yield of 1.86% for the formation of PyP-dR.12
4
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Figure 13. Time dependent depurination of 7-Me-PyP-dR at 50°C. Fluorescent profiles (Xm= 370, 342 nm)
on C18 Analytical column (flow = 1 ml/min) at a) 2 hr (0-15% CH3CN/H20 from 20-30 min) and b) 72 hr 
(0-15% CH3CN/H20 in 20 min). A = 7-Me-PyP, B = 7-Me-PyP-dR.
4
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B. Attempts at the Synthesis of 7-Me-PyP-pdRp
Three different approaches for the preparation of 7-Me-PyP-pdRp were 
pursued. These are as follows:
1. Bisphosphorylation Attempts on 7-Me-PyP-dR.
Barrio, et. al,,36 predicted the bisphosphorylation of dG and 7-Me-PyP-dR by 
pyrophosphoryl chloride as shown in the following reaction:
O
Once phosphorylated, pdGp or 7-Me-PyP-pdRp could be used as the substrate for the 
T4-RNA ligase reaction. Numerous reactions were run to test this hypothesis.
Initial reactions employed Barrio’s procedure for the bisphosphorylation of 
guanosine and 7-Me-PyP-R36 with 7-Me-PyP-dR as starting material (see Experimental 
Section). Most experiments, upon addition of pyrophosphoryl chloride, turned instantly 
to a brown tar. This was due to incomplete drying of starting material. Of the reactions 
that worked, usually only two products were detected, starting material and depurinated 
product (14a).
Fearing that the adduct maybe enhancing the depurination, deoxyguanosine 
was used as a starting material instead of the 7-Me-PyP-dR. Results were still negative; 
deoxyguanosine did not form bisphosphate but depurinated. In order to discover the
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reason for depurination, the pH of the reaction mixture before quenching the reaction 
mixture was tested (the mixture contained only the starting materials, dG and pyrophos- 
phoryl chloride). The pH was found to be less than 2. Therefore, it seemed obvious that 
it was the low pH that caused the depurination and that this pathway was not a viable ex­
tension to form the substrate for the ligase reaction, 7-Me-PyP-pdRp from the 2’-deox- 
yribose, 7-Me-PyP-R.
Subsequent attempts were made to modify the procedure by using anhydrous 
solvents and greater concentrations of buffer. Even the best results did not lead to the 
desired bisphosphate product, but only produced the monophosphorylated product (refer 
to Figure 14b).
2. Attempted Synthesis of 7-Me-PyP-dR from a-Me-MDA and pdGp.
The procedure followed was similar to the above synthesis of 7-Me-PyP-dR in 
which a-Me-MDA was hydrolyzed to its acid form, a-Me-P-hydroxyacrolein, and 
added to pdGp in DMSO. Likewise a few milligrams of MgS04 were also added. 
Unlike the deoxyribose reaction the temperature was lower with a longer reaction time 
(37°C and 3 days) due to the lower stability of the phosphates. Unfortunately, the yields 
were too low to get conclusive identification of 7-Me-PyP-pdRp.
3. Attempted Synthesis of 7-Me-PyP-pdRp from P-Benzoyloxy-a-methylacrolein 
and pdGp.
Based on the fact that good leaving groups in the P-position of acroleins 
enhance the mutagenicity and therefore possible reactivity with nucleotides, 
P-Benzoyloxy-a-methylacrolein was used as a starting material to increase the yield of 
7-Me-PyP-pdRp. The appearance of the adduct was not evident based on fluorescence
Figure 14. Bisphosphorylation UV profiles from Cl8 Analytical Column (flow = 1 ml/min) with 
a) 7-Me-PyP-dR (0-20% CH3CN/O.I M TEAA pH 6.5 in 30 min. Note only starting material, A, 
and depurinated, B, were formed) and b) 2’-deoxyguanosine (dG) in which only monophosphorylated 
dG was formed (0-30% CH3CN/0.1 M TEAA pH 6.5 in 20 mm. A = 7-Me-PyP, B = 7-Me-PyP-dR 
C = monophosphorylated dG, D = dG.
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and in the 'H-NMR, only benzoic acid was distinguishable.
C. Synthesis of pdeGp
A new substrate for the ligase reaction, pdeGp, an adduct similar in structure to 
7-Me-PyP-pdRp, was synthesized. The adduct was prepared by adding 2, 3 - epoxybu­
tanol to pdGp in the following reaction:
2, 3-Epoxybutanol
Purification of the deoxynucleotide was somewhat more difficult than previously report­
ed32 because the phosphorylated adduct did not precipitate from solution as the 
unphosphorylated product does. After HPLC separation the 1 H-NMR revealed the 
major product to be the desired adduct, pdeGp, in a 35% yield. In the 1 H-NMR, the
C’ C” O’
sugar protons, H ’ , and H are shifted downfield indicative of the attached 3’, 5’-
phosphates (refer to Figure 15).
D. T4-RNA Ligase
Several authors have successfully utilized T4-RNA ligase for the formation of 
a small adducted oligonucleotide at a specific site.36 20 The mechanism involves the
a
7
10 8 6 4 2 0 PPM
Figure 15. 'H-NMR comparison between a) pdeGp in D2Q and b) dfG in DMSO-d6
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ligation of the donor (pdeGp or G*) to the 3’-OH of the acceptor molecule (dCdGdC) as 
shown in Figure 16.
Figure 16. Enzymatic synthesis of an oligodeoxyribonucleotide by
T^-RNA Ligase, R = HO-dCpdG
To determine the extent of successful ligation, every ligation experiment 
contained a standard reaction (a separate tube) which contained pdGp as the acceptor 
instead of adducted bisphosphate, pdeGp. Initial experiments were designed to 
determine if pdeGp was a substrate for the enzyme. These experiments indicated that 
pdeGp is a poor substrate. The yield for dCpdGpdCpdeGp appeared close to 1% (refer 
to Figure 17). To test if pdeGp was inhibiting the ligase, pdGp was run in the same tube 
along with pdeGp. Both ligation products, dCpdGpdCpdGp and dCpdGpdCpdeGp did 
appear to be formed (refer to Figure 18). Thus pdeGp was not a complete inhibitor of 
the ligase but a competitive substrate with pdGp for ligation.
Even though pdeGp was not completely inhibiting the enzyme, the yields for 
the ligation were low and did not run to completion. The pdeGp was repurified on 
HPLC to remove any impurities that may be inhibiting the ligation. Triethylamine 
impurities were found in the 0.1M TEAB buffer and removed by distilling the TEA over
Figure 17. T4-RNA ligation of a) pdGp and b) pdeGp with dCdGdC 
A = dCdGdCdGp, B = dCdGdC, C = dCdGdCdeGp?
D Cf
Figure 18. T4-RNA Ligation with both pdGp and pdeGp. A = 5'-Adenylated donor?, 
B = dCdGdC, C = dCdGdCdGp, D = dCdGdCdeGp?
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~0.5%C1SO^ onto KOH pellets, redistilling and collecting at 89°C. Buffers were pre­
pared just prior to use since storage at 4°C overnight resulted in detectable impurities by 
UV and fluorescence spectroscopy. After purification of pdeGp, its yield of ligation to 
form dCpdGpdCpdeGp seemed to increase slightly (Figure 19).
Several other attempts were made to increase the yield of the reaction.
Tessier’s modifications3 ' of an added polymer (25% polyethylene glycol, PEG) and low 
ATP concentrations were applied to the technique. Twenty-five percent PEG increased 
the yield slightly but the ATP modification of removing the regeneration system (phos- 
phocreatine, creatine phosphokinase, and adenylate kinase omitted from reaction mix­
ture) didn’t appear to change the yield.
Attempts to scale up the standard reaction (2x and lOx) did not increase 
product yield. With an increase of 10 fold, no product was observed. In the 2 fold 
experiment, after 2 days, the product reached about 10% then dropped. The addition of 
more enzyme appeared to inhibit ligation. The yield for any reaction (either substrate, 
pdGp or pdeGp) was below 50% and variable depending on the specific activity of the 
enzyme.
T4-RNA ligase purchased from different companies produced very different 
yields. Yields directly correlated with the specific activity of the enzyme purchased. 
Ligations involving the Pharmacia enzyme (27 units, 9000 units/ ml) gave the best 
yields as denoted in reactions with the “standard”, pdGp and d(pA)4. Bethesda 
Research labs (BRL, 18 units, 6000 units/ml) had slightly lower yields while Biolabs (12 
units, 4000 units/ml) enzyme had a very low yield in comparison (refer to Figure 20). 
Although Biolabs ligase gave very poor yields the enzyme was not as sensitive to amine
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impurities as the other ligases, BRL and Pharmcia.
Figure 19. UV profiles (A. = 250) of the formation of dCpdGpdCpdsGp by T4-RNA Ligase on Spherisorb S5 
SAX column, 10^40% 1 M KH2P04, 5% MeOH/5% MeOH in 20 min. a) Reaction at time = 0. b) Reaction 
after 7 days. Note formation of C at 38 min. A = pdeGp, B = dCpdGpdC, C = dCpdGpdCpdeGp.
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a b c
Figure 20. T4-RNA Ligase comparison between a) Biolabs b) BRL and c) Pharmacia,
A - d(pA)4, B = dApdApdApdApdGp (ligation product). Spherisorb S5 SAX column 
10-40% 1 M KH2P04, 5% MeOH/ 5% MeOH in 40 min.
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IV. DISCUSSION
Two different strategies were applied to the synthesis of 7-Me-PyP-pdRp, the 
T4-RNA ligase donor substrate: Phosphorylating the adduct and modifying the 3’, 5’- 
bisphosphorylated deoxyguanosine. Phosphorylating the adduct would be preferred due 
to economic reasons.
Phosphorylation of 7-Me-PyP-dR was proposed as a plausible reaction, be­
cause 7-Me-PyP-ribose can be successfully phosphorylated.36 Initially, experiments 
were conducted to synthesize 7-Me-PyP-dR because the adduct’s preparation gives few 
side products and good yields, and 3’, 5’ -bisphospho-2’-deoxyguanosine is very 
expensive ($250/5()mg, Pharmacia). The yield for the synthesis of 7-Me-PyP-dR was 
increased greatly over previous literature for PyP-dR from 1.86%12 to 25%. This was 
accomplished by the addition of MgS04, the use of a high concentration of reactants, 
and by optimizing the temperature and duration such that maximum yield was obtained 
with as little depurination as possible.
MgS04 is known to complex or trap water. Molecular sieves (3A), also known 
for their ability to trap water, were tested and compared to MgS04 for enhanced 
production of 7-Me-PyP-dR. Molecular sieves did not work nearly as well as MgS04 
(refer to Figure 10). In fact molecular sieves yield more depurinated product than 7-Me- 
PyP-dR (refer to Figure 11). MgS04, on the other hand, produces more 7-Me-PyP-dR 
than the depurinated form, 7-Me-PyP (refer to Figure 12). Either entrapment of water 
by MgS04 acts as a driving force for the condensation, the elimination of water helps to 
prevent depurination, or it is a combination of the two that enables the MgS04 to
increase the yield of the 7-Me-PyP-dR. Molecular seives do not accomplish this same 
phenomena probably because they trap MDA.
In order for 7-Me-PyP-dR to be utilized as substrate for the enzymatic reaction 
it had to be phosphorylated. Although Barrio, et. al.36 has proposed bisphosphorylation 
of dG and 7-Me-PyP-dR our attempts with their method were futile. The pH for the 
reaction was too low thus the product depurinated (refer to Figure 14a). Any attempts to 
modify the procedure, such as utilizing solvents or buffers, did not result in the bisphos- 
phorylated but only the monophosphorylated product (refer to Figure 14b).
The approach was then turned towards adducting pdGp. The reaction of MDA 
with pdGp yielded virtually no product. Basu16 has shown that increasing the leaving 
group ability of a series of acrolein substituted on the (3-carbon increased their 
mutagenicity. Therefore (3-benzoyloxyacrolein, a compound with a very good leaving 
group on the (3-carbon of acrolein, was used in the attempted synthesis of 7-Me-PyP- 
pdRp. The benzoic acid that formed from the (3-leaving group proved to be more detri­
mental to the stability of the purine than beneficial to the yield. Neither starting material 
nor product, only benzoic acid, was detected in the ^H-NMR.
Due to the lack of success with PyP, etheno-2’-deoxyguanosine, deG, an 
adduct with a very similar structure to the PyP base was employed (Figure 22). pdeGp 
was readily obtained by the reaction of pdGp with 2, 3-epoxybutanal with an overall 
yield of 35%. The 'H-NMR revealed a downfield shift of the all the sugar protons 
except H4 indicating that both phosphates were present (refer to Figure 15a,b). The 
ligase acceptor, dCpdGpdC, was readily synthesized on a DNA sequencer and purified 
by C-18 analytical HPLC. These substrates were then used for ligation.
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Figure 22. MDA adduct, pd(PyP)p, structure comparison with pdeGp
Many problems arose in the ligation reactions. Not only was the enzyme, T4- 
RNA ligase, difficult to purchase with a high specific activity but a method of detection 
had to be developed. Originally the reaction mixture was separated with an ion- 
exchange column (Micropak and Spherisorb S5 SAX) but soon after use the retention 
times changed drastically. Without consistent retention times it was difficult to distin­
guish product peaks from impurities; results became incomparable. It is uncertain why 
column performance was inconsistent; perhaps the EDTA added to chelate the Mg+i' 
affected the column. Techniques established by other researchers36 proved infeasible 
because the anion exchange columns were unobtainable (Rainin or Phase Sep S5 SAX 
column on back-order for 9 months). Using a readily available Beckman C-18 
Analytical column and ion-pairing, HPLC separation between substrates and products 
was obtained (refer to Figure 8).
The ligase reaction did show some promise. There appears to be product, a 
peak at 38 min that increases over time (refer to Figure 19). The pdeGp is obviously not 
as good a substrate as the standard, dG. Reactions with the substrates under the same 
conditions produce a greater percent ligation of dG than pdeGp (refer to Figure 17). As
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Figure 18 shows, pdeGp does not completely inhibit the ligase and once the amine 
impurities were removed the ligation increased (compare Figure 17 with Figure 19).
The substrate ligation not only seemed to be dependent on the purity of the 
substrate but also changed for the various enzymes (different suppliers of the T4-RNA 
ligase). The enzyme with the highest specific activity, Pharmacia’s, performed ligation 
to the greatest extent (refer to Figure 20). The Pharmacia ligase was also more sensitive 
to impurities then the other enzyme suppliers, Biolabs and BRL, tested. With any impu­
rities present (detected by ]H-NMR), ligation for the Pharmacia enzyme dropped from 
about 50% ligation to less then 10% while the Biolabs enzyme only ligated about 3% 
but was insensitive to the presence of impurities (results not shown).
Unfortunately, not enough material was produced to enable complete 
characterization. Several variations of the method were attempted to improve the mass 
and yield of the product, dCpdGpdCpdeGp, (e.g. scaling up the reaction mixture and 
adding PEG) yet none were successful. The substrate, pdeGp, is a poor substrate in 
comparison to dG with only about 10% ligation compared to almost 50% found for dG.
Often noted in HPLC profiles for the ligation of pdeGp but not the standard, 
pdGp, is thought to be AMP-pdeGp (refer to Figure 7 and Figure 18). Perhaps the rea­
son pdeGp is a poor substrate is due to this structure. Uhlenbeck and Gumport35 noted 
that once the donor is adenylylated, ATP and the enzyme are no longer required for liga­
tion to occur. Perhaps the yields can be improved if the adenylated donor, AMP-pdeGp, 
could be isolated and reacted with the acceptor, dCpdGpdC. Gumport21 also noted that 
base helps to shift the equilibrium from adenylylated donor, AMP-pdeGp, to product.
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pH studies of the reaction could denote optimum pH for maximum yields. If yields 
could be improved such that the identification of the product was evident, the ligation of 
dCpdGpdC to pdeGp by T4-RNA ligase would be a useful method.
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VI. ABSTRACT
SYNTHESIS OF SITE SPECIFIC 1, N2-ETHENODEOXYGUANOSINE 
IN A SMALL OLIGONUCLEOTIDE
by
KATHRYN A. CAROLIN 
December, 1989
Adviser: Dr. Lawrence J. Marnett 
Major: Chemistry 
Degree: Master of Science
Malondiadehyde (MDA) is a known carcinogen and mutagen produced by 
lipid peroxidation and prostaglandin synthesis in vivo. MDA is unique from structural­
ly related compounds, methyl glyoxal and acrolein, because it produces frameshift muta­
tions whereas the latter compounds induce base-pair substitutions. MDA forms several 
adducts with deoxyguanosine but it is not certain which one causes the frameshift muta­
tions. Ideally, a single adduct on a replicating genome could simulate the in vivo pro­
cess by which MDA mutagenesis would occur. This technique is known as site-specific 
mutagenesis. The approach of choice for site-specific mutagenesis experiment is the 
gapped heteroduplex method which requires the formation of a small oligonucleotide 
with an adduct at a defined site. The construction of the oligonucleotide with the site 
specific adduct was attempted by ligating an adducted bisphosphate to the oligonucle­
otide, dCpdGpdC, with T4-RNA ligase. The synthesis of 3’, 5’-bisphosphoryl-7-
methyl-3-(f3-D-pentofuranosyl)-pyrimido [1, 2-a] purine-10-(3H)-one-2’-deoxyribose 
(7-Me-PyP-pdRp) was attempted. Although modification of the synthesis of 7-methyl- 
3-(p-D-pentofuranosyl)-pyrimido [1, 2-a] purine-10-(3H)-one-2’-deoxyribose, the pre- 
cusor to 7-Me-PyP-pdRp, with MgS04 and minimal concentrations of reactants im­
proved the yield to 25%, the bisphosphate could not be formed. An adduct similar in 
structure to the MDA adduct was employed. The adduct, formed from 2, 3-epoxybuta- 
nal under basic conditions in a 35% yield, was 3’, 5’-bisphosphoryl-l, N -etheno-2’- 
deoxyguanosine.
Substrates, pdeGp and dCpdGpdC, for the T4-RNA ligase were successfully 
prepared. Ligation appeared successful, based on UV profiles, except possitive identifi 
cation of the oligonucleotide product, dCpdGpdCpdeGp, was not possible due to low 
yields. Any modifications to increase the yield such as scale up attempts and polyethyl 
ene glycol addition were ineffective.
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